Fucoxanthin triggers ferroptosis in glioblastoma cells by stabilizing the transferrin receptor

Med Oncol. 2023 Jul 8;40(8):230. doi: 10.1007/s12032-023-02095-6.

Abstract

Glioblastoma (GBM) is the most common and lethal tumor in the world, possessing high stemness, aggressiveness and resistance. Fucoxanthin is a bio-active compound extracted from seaweeds that shows anti-tumor effects to different types of tumors. Here, we show that fucoxanthin inhibits the survival of GBM cells by triggering ferroptosis, a ferric ion and reactive oxygen species (ROS) dependent cell death and ferrostatin-1 could block it. Furthermore, we identified that fucoxanthin targets the transferrin receptor (TFRC). Fucoxanthin is able to block degradation and maintain high levels of TFRC, and similarly inhibits the growth of GBM xenografts in vivo, downregulates the expression of proliferating cell nuclear antigen (PCNA) and upregulates the levels of TFRC in tumor tissues. In conclusion, we demonstrate that fucoxanthin has a significant anti-GBM effect by triggering ferroptosis.

Keywords: Ferroptosis; Fucoxanthin; Glioblastoma; TFRC.

MeSH terms

  • Cell Line, Tumor
  • Ferroptosis*
  • Glioblastoma* / metabolism
  • Humans
  • Receptors, Transferrin

Substances

  • fucoxanthin
  • Receptors, Transferrin